All Shops

Go to British Wildlife

6 issues per year 84 pages per issue Subscription only

British Wildlife is the leading natural history magazine in the UK, providing essential reading for both enthusiast and professional naturalists and wildlife conservationists. Published six times a year, British Wildlife bridges the gap between popular writing and scientific literature through a combination of long-form articles, regular columns and reports, book reviews and letters.

Subscriptions from £25 per year

Conservation Land Management

4 issues per year 44 pages per issue Subscription only

Conservation Land Management (CLM) is a quarterly magazine that is widely regarded as essential reading for all who are involved in land management for nature conservation, across the British Isles. CLM includes long-form articles, events listings, publication reviews, new product information and updates, reports of conferences and letters.

Subscriptions from £18 per year
Academic & Professional Books  Botany  Economic Botany & Ethnobotany

Algae-Based Biopharmaceuticals

By: Sergio Rosales-Mendoza(Author)
162 pages, 22 colour & 25 b/w illustrations, 23 colour tables
Publisher: Springer-Verlag
Algae-Based Biopharmaceuticals
Click to have a closer look
Select version
  • Algae-Based Biopharmaceuticals ISBN: 9783319322308 Hardback Jun 2016 Usually dispatched within 1-2 weeks
    £119.99
    #229284
Selected version: £119.99
About this book Contents Customer reviews Biography Related titles

About this book

Algae-Based Biopharmaceuticals constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems.

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although Algae-Based Biopharmaceuticals is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.
 

Contents

- The Biopharmaceuticals Field and Algae as Expression Hosts
- Genetic Engineering Approaches for Algae
- Algae-made Vaccines Targeting Human Diseases
- Algae-made Vaccines Targeting Animal Pathogens
- Algae-made Antibodies and Immunotoxins
- Algae-made Cytokines and Growth Factors
- Other Biopharmaceuticals Produced in Algae
- Algae-made Nutraceuticals
- Perspectives for the Algae-made Biopharmaceuticals Field

Customer Reviews

Biography

Dr. Sergio Rosales-Mendoza is professor of Biotechnology and has worked in the area of biopharmaceuticals produced in low-cost platforms for the past 10 years. Over his career, Dr. Rosales-Mendoza has published several scientific refereed articles in international high-impact scientific journals.

By: Sergio Rosales-Mendoza(Author)
162 pages, 22 colour & 25 b/w illustrations, 23 colour tables
Publisher: Springer-Verlag
Current promotions
Backlist BargainsThe Mammal SocietyOrder your free copy of our 2018 equipment catalogueBritish Wildlife